ASP Isotopes (ASPI) Revenue (2023 - 2026)

ASP Isotopes' Revenue history runs 4 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• On a quarterly basis, Revenue rose 279.31% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $26.9 million, a 511.2% increase from a year earlier, with the FY2025 full-year figure at $23.8 million, up 475.51% from the prior year.
• Revenue slipped to $4.2 million in Q1 2026 per ASPI's latest filing, from $16.7 million in the prior quarter.
• Across five years, Revenue topped out at $16.7 million in Q4 2025 and bottomed at $433026.0 in Q4 2023.
• The 4-year median for Revenue is $1.1 million (2024), against an average of $3.3 million.
• Biggest YoY gain for Revenue was 1295.68% in 2025; the steepest drop was 17.22% in 2025.
• Year by year, Revenue stood at $433026.0 in 2023, then soared by 175.65% to $1.2 million in 2024, then soared by 1295.68% to $16.7 million in 2025, then slumped by 74.91% to $4.2 million in 2026.
• Per Business Quant, the three latest ASPI Revenue figures stand at $4.2 million (Q1 2026), $16.7 million (Q4 2025), and $4.9 million (Q3 2025).